| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106.9M | — | +0.9% |
| R&D Expense | $12.3M | — | +16.8% |
| SG&A Expense | $29.4M | — | +49.5% |
| Operating Income | -$4.3M | — | -156.4% |
| Pre-tax Income | -$7.9M | — | -274.9% |
| Income Tax | $820K | — | +508.0% |
| Net Income | -$8.8M | — | -284.8% |
| EPS (Basic) | -$0.06 | — | -300.0% |
| EPS (Diluted) | -$0.06 | — | -300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $149.5M | -21.1% | -16.5% |
| Accounts Receivable | $83.2M | -12.0% | +6.8% |
| Current Assets | $270.6M | -14.1% | -9.9% |
| Total Assets | $1.50B | -3.6% | -3.9% |
| Current Liabilities | $144.1M | -6.0% | +33.3% |
| Long-term Debt | $292.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $11.7M | — | -32.6% |
| Capital Expenditures | $631K | — | +5.2% |
| Investing Cash Flow | -$6.8M | — | -17.4% |
| Financing Cash Flow | -$43.7M | — | -212.5% |
| Free Cash Flow | $11.1M | — | -34.0% |
| -0.8% |
| Total Liabilities | $483.3M | -2.1% | +1.4% |
| Stockholders' Equity | $1.02B | -4.3% | -6.2% |